Panacea Life Sciences HoldingsPLSH +11.11% 3-Year ROIIC % is 3.52 as of Dec. 2023, which is at its 10-year median of 3.52. The stock has 6 warning signs investors should review. Among 941 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks worse than 50.58% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Panacea Life Sciences Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 3.52%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
PLSH's 3-Year ROIIC % is ranked worse than 50.58% of 941
companies
in the Drug Manufacturers industry
Industry Median: 3.7
vs PLSH: 3.52
Panacea Life Sciences Holdings (OTCPK:PLSH) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Panacea Life Sciences Holdings 3-Year ROIIC % Related Terms
Panacea Life Sciences Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings 3-Year ROIIC % Chart
PLSH vs SKYI, IMCC, CBDY: 3-Year ROIIC % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -5.546 (Dec. 2023) - -5.258 (Dec. 2020) )
/
( 28.145 (Dec. 2023) - 36.337 (Dec. 2020) )
=
-0.288
/
-8.192
=
3.52%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Panacea Life Sciences Holdings (PLSH) has a 3-Year ROIIC % of 3.52 as of Dec. 2023. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Panacea Life Sciences Holdings and its competitors. This is near median its historical median of 3.52. Over the past decade, Panacea Life Sciences Holdings' 3-Year ROIIC % has ranged from 3.52 to 3.52. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #476 out of 941 companies in the Drug Manufacturers industry, placing it in the top 50.6%.
Is Panacea Life Sciences Holdings' 3-Year ROIIC % too high?
Panacea Life Sciences Holdings' current 3-Year ROIIC % of 3.52 is near median its 10-year median of 3.52. Over the past 10 years, this metric has ranged from a low of 3.52 to a high of 3.52. The Drug Manufacturers industry median 3-Year ROIIC % is 3.70. Panacea Life Sciences Holdings' value of 3.52 is 4.9% below this industry median. Based on the distribution chart, Panacea Life Sciences Holdings ranks #476 out of 941 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Panacea Life Sciences Holdings' 3-Year ROIIC % compare to SKYI and IMCC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #476 out of 941 companies for 3-Year ROIIC %. This places Panacea Life Sciences Holdings in the lower half of its industry. The industry median 3-Year ROIIC % is 3.70. Panacea Life Sciences Holdings' value of 3.52 is 4.9% below this benchmark. Historically, Panacea Life Sciences Holdings' own 3-Year ROIIC % has ranged from 3.52 to 3.52 over the past decade. While the company's 10-year median is 3.52 vs. the industry median of 3.70, Panacea Life Sciences Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.70, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panacea Life Sciences Holdings's current 3-Year ROIIC % of 3.52 is 4.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Panacea Life Sciences Holdings and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panacea Life Sciences Holdings's current 3-Year ROIIC % is 3.52, which is near median its own 10-year median of 3.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current 3-Year ROIIC % of 3.52. The current 3-Year ROIIC % is 3.52, which is near median its 10-year median of 3.52 and 4.9% below the Drug Manufacturers industry median of 3.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current 3-Year ROIIC % is 3.52 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Panacea Life Sciences Holdings Business Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSH has been successfully added to your 